Translational new approaches for investigating mood disorders in rodents and what they may reveal about the underlying neurobiology of major depressive disorder

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 373, Issue 1742, 2018, Pages

  Robinson, Emma S J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Affective bias; Animal model; Major depressive disorder; Neuropsychology; Neurotrophic

Indexed keywords

BEHAVIORAL RESPONSE; DISABILITY; MENTAL HEALTH; NERVOUS SYSTEM DISORDER; NEUROLOGY; NUMERICAL MODEL; PSYCHOLOGY; RESEARCH PROGRAM; RODENT; SYMPTOM;

ANIMALIA; RODENTIA;

ANIMAL; DISEASE MODEL; MAJOR DEPRESSION; MOOD DISORDER; MOUSE; PATHOPHYSIOLOGY; PSYCHOLOGY; RAT; TRANSLATIONAL RESEARCH;

ANIMALS; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; MICE; MOOD DISORDERS; RATS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 85040913294     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2017.0036     Document Type: Review

References (100)

1. Stuart SA, Butler P, Robinson ES. 2014 Animal models of risk factors for suicidal ideation and behaviour. In Suicide: phenomenology and neurobiology, Chapter 18 (eds KE Cannon, TJ Hudzik), pp. 295–314. Cham, Switzerland: Springer International Publishing.
2. Rumsfeld JS, Nallamothu BK. 2008 The hope and fear of rimonabant. JAMA 299, 1601–1602. (doi:10.1001/jama.299.13.1601)
3. Bremner JD, McCaffery P. 2008 The neurobiology of retinoic acid in affective disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 315 –331. (doi:10.1016/j.pnpbp.2007. 07.001)
4. Raison CL, Demetrashvili M, Capuron L, Miller AH. 2005 Neuropsychiatric adverse effects of interferon-α: recognition and management. CNS Drugs 19, 105–123. (doi:10.2165/00023210-200519020-00002)
5. Slattery DA, Hudson AL, Nutt DJ. 2004 Invited review: the evolution of antidepressant mechanisms. Fundam. Clin. Pharmacol. 18, 1–21. (doi:10.1111/j.1472-8206.2004.00195.x)
6. American Psychiatric Association. 2013 Diagnostic and statistical manual of mental disorders, 5th edition. Washington, DC: American Psychiatric Association.
7. Willner P. 1984 The validity of animal models of depression. Psychopharmacology (Berl.) 83, 1–16. (doi:10.1007/BF00427414)
8. Geyer MAMA. 1995 Animal models of psychiatric disorders. In Psychopharmacology: the fourth generation of progress (eds F Bloom, D Kupfer), pp. 787–798. New York, NY: Raven Press.
9. Belzung C, Lemoine M. 2011 Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. Biol. Mood Anxiety Disord. 1, 9. (doi:10.1186/2045-5380-1-9)
10. Nestler EJ, Gould E, Manji H. 2002 Preclinical models: status of basic research in depression. Biol. Psychiatry 52 503–528. (doi:10.1016/S0006-3223(02)01405-1)
11. Willner P. 2005 Chronic mild stress (CMS) revisited: consistency and behavioural –neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90–110. (doi:10.1159/000087097)
12. Cryan JF, Holmes A. 2005 The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov. 4, 775–790. (doi:10. 1038/nrd1825)
13. Cryan JF, Slattery DA. 2007 Animal models of mood disorders: recent developments. Curr. Opin. Psychiatry 20, 1–7. (doi:10.1097/YCO. 0b013e3280117733)
14. McArthur RA, Borsini F. 2008 PREFACE: What do you mean by ‘translational research’? An enquiry through animal and translational models for CNS drug discovery: psychiatric disorders, in animal and translational models for CNS drug discovery, pp. xvii –xxxviii. San Diego, CA: Academic Press:
15. Nestler EJ, Hyman SE. 2010 Animal models of neuropsychiatric disorders. Nat. Neurosci. 13, 1161–1169. (doi:10.1038/nn.2647)
16. Hales CA, Stuart SA, Anderson MH, Robinson ESJ. 2014 Modelling cognitive affective biases in major depressive disorder using rodents. Br. J. Pharmacol. 171, 4524 –4538. (doi:10. 1111/bph.12603)
17. Berton O, Hahn CG, Thase ME. 2012 Are we getting closer to valid translational models for major depression? Science 338, 75–79. (doi:10.1126/science.1222940)
18. Slattery DA, Cryan JF. 2017 Modelling depression in animals: at the interface of reward and stress pathways. Psychopharmacology (Berl.) 234, 1451–1465. (doi:10.1007/s00213-017-4552-6)
19. Commons KG, Cholanians AB, Babb JA, Ehlinger DG. 2017 The rodent forced swim test measures stress-coping strategy, not depression-like behavior. ACS Chem. Neurosci. 8, 955–960. (doi:10.1021/acschemneuro.7b00042)
20. Porsolt RD, Le Pichon M, Jalfre M. 1977 Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730–732. (doi:10.1038/266730a0)
21. Steru L, Chermat R, Thierry B, Simon P. 1985 The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl.) 85, 367–370. (doi:10.1007/BF00428203)
22. Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M. 1979 Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur. J. Pharmacol. 57, 201–210. (doi:10.1016/0014-2999(79)90366-2)
23. Slattery DA, Cryan JF. 2014 The ups and downs of modelling mood disorders in rodents. ILAR J. 55, 297–309. (doi:10.1093/ilar/ilu026)
24. Zacharko RM, Anisman H. 1991 Stressor-induced anhedonia in the mesocorticolimbic system. Neurosci. Biobehav. Rev. 15, 391–405. (doi:10. 1016/S0149-7634(05)80032-6)
25. Willner P, Muscat R, Papp M. 1992 Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Rev. 16, 525–534. (doi:10.1016/S0149-7634(05)80194-0)
26. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. 1987 Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl.) 93, 358–364. (doi:10. 1007/BF00187257)
27. Dichter GS, Smoski MJ, Kampov-Polevoy AB, Gallop R, Garbutt JC. 2010 Unipolar depression does not moderate responses to the sweet taste test. Depress Anxiety 27, 859–863. (doi:10.1002/da.20690)
28. Sherdell L, Waugh CE, Gotlib IH. 2012 Anticipatory pleasure predicts motivation for reward in major depression. J. Abnorm. Psychol. 121, 51–60. (doi:10.1037/a0024945)
29. Ramaker MJ, Dulawa SC. 2017 Identifying fast-onset antidepressants using rodent models. Mol. Psychiatry 22, 656–665. (doi:10.1038/mp. 2017.36)
30. Dulawa SC, Hen R. 2005 Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci. Biobehav. Rev. 29, 771–783. (doi:10.1016/j. neubiorev.2005.03.017)
31. Robinson ES, Roiser JP. 2016 Affective biases in humans and animals. Curr. Top. Behav. Neurosci. 28, 263–286. (doi:10.1007/7854_2015_5011)
32. Gur RC, Erwin RJ, Gur RE, Zwil AS, Heimberg C, Kraemer HC. 1992 Facial emotion discrimination: II. Behavioral findings in depression. Psychiatry Res. 42, 241–251. (doi:10.1016/0165-1781(92)90116-K)
33. Williams JM, Barnhofer T, Crane C, Herman D, Raes F, Watkins E, Dalgleish T. 2007 Autobiographical memory specificity and emotional disorder. Psychol. Bull. 133, 122–148. (doi:10.1037/0033-2909.133.1.122)
34. Surguladze S, Brammer MJ, Keedwell P, Giampietro V, Young AW, Travis MJ, Williams SC, Phillips ML. 2005 A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol. Psychiatry 57, 201–209. (doi:10.1016/j.biopsych.2004.10.028)
35. Leppänen J. 2006 Emotional information processing in mood disorders: a review of behavioral and neuroimaging findings. Curr. Opin. Psychiatry 19, 34–39. (doi:10.1097/01.yco.0000191500.46411.00)
36. Ressler KJ, Mayberg HS. 2007 Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat. Neurosci. 10, 1116–1124. (doi:10.1038/nn1944)
37. Mathews A, MacLeod C. 2005 Cognitive vulnerability to emotional disorders. Annu. Rev. Clin. Psychol. 1, 167–195. (doi:10.1146/annurev.clinpsy.1.102803. 143916)
38. Gotlib IH, Joormann J. 2010 Cognition and depression: current status and future directions. Annu. Rev. Clin. Psychol. 6, 285–312. (doi:10.1146/annurev.clinpsy.121208.131305)
39. Elliott R, Zahn R, Deakin JFW, Anderson IM. 2011 Affective cognition and its disruption in mood disorders. Neuropsychopharmacology 36, 153–182. (doi:10.1038/npp.2010.77)
40. Roiser JP, Elliott R, Sahakian BJ. 2012 Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 37, 117–136. (doi:10. 1038/npp.2011.183)
41. Paul ES, Harding EJ, Mendl M. 2005 Measuring emotional processes in animals: the utility of a cognitive approach. Neurosci. Biobehav. Rev. 29, 469–491. (doi:10.1016/j.neubiorev.2005.01.002)
42. Beck AT. 1967 Depression: clinical, experimental, and theoretical aspects. Hoeber Medical Division, NY: Harper & Row.
43. Beck AT. 2008 The evolution of the cognitive model of depression and its neurobiological correlates. Am. J. Psychiatry 165, 969–977. (doi:10.1176/appi. ajp.2008.08050721)
44. Bouhuys AL, Bloem GM, Groothuis TG. 1995 Induction of depressed and elated mood by music influences the perception of facial emotional expressions in healthy subjects. J. Affect. Disord. 33, 215–226. (doi:10.1016/0165-0327(94)00092-N)
45. Hayward G, Goodwin GM, Cowen PJ, Harmer CJ. 2005 Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms. Biol. Psychiatry 57, 517–524. (doi:10.1016/j.biopsych. 2004.11.016)
46. Joormann J, Gotlib IH. 2006 Is this happiness I see? Biases in the identification of emotional facial expressions in depression and social phobia. J. Abnorm. Psychol. 115, 705–714. (doi:10.1037/0021-843X.115.4.705)
47. Joormann J, Gotlib IH. 2007 Selective attention to emotional faces following recovery from depression. J. Abnorm. Psychol. 116, 80–85. (doi:10.1037/0021-843X.116.1.80)
48. Chan SW, Goodwin GM, Harmer CJ. 2007 Highly neurotic never-depressed students have negative biases in information processing. Psychol. Med. 37, 1281–1291. (doi:10.1017/S0033291707000669)
49. McCabe SB, Gotlib IH. 1995 Selective attention and clinical depression: performance on a deployment-of-attention task. J. Abnorm. Psychol. 104, 241–245. (doi:10.1037/0021-843X. 104.1.241)
50. Brittlebank AD, Scott J, Williams JM, Ferrier IN. 1993 Autobiographical memory in depression: state or trait marker?. Br. J. Psychiatry 162, 118–121. (doi:10.1192/bjp.162.1.118)
51. Papadatou-Pastou M, Miskowiak KW, Williams JMG, Harmer CJ, Reinecke A. 2012 Acute antidepressant drug administration and autobiographical memory recall: a functional magnetic resonance imaging study. Exp. Clin. Psychopharmacol 20, 364–372. (doi:10.1037/a0027969)
52. Harmer CJ, Bhagwagar Z, Perrett DI, Völlm BA, Cowen PJ, Goodwin GM. 2003 Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28, 148–152. (doi:10.1038/sj.npp.1300004)
53. Harmer CJ, Hill SA, Taylor MJ, Cowen PJ, Goodwin GM. 2003 Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. Am. J. Psychiatry 160, 990–992. (doi:10. 1176/appi.ajp.160.5.990)
54. Harmer CJ, Goodwin GM, Cowen PJ. 2009 Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br. J. Psychiatry 195, 102–108. (doi:10. 1192/bjp.bp.108.051193)
55. Pringle A, Browning M, Cowen PJ, Harmer CJ. 2011 A cognitive neuropsychological model of antidepressant drug action. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1586–1592. (doi:10.1016/j.pnpbp. 2010.07.022)
56. Stuart SA, Butler P, Munafò MR, Nutt DJ, Robinson ESJ. 2013 A translational rodent assay of affective biases in depression and antidepressant therapy. Neuropsychopharmacology 38, 1625–1635. (doi:10. 1038/npp.2013.69)
57. Stuart SA, Butler P, Munafò MR, Nutt DJ, Robinson ESJ. 2015 Distinct neuropsychological mechanisms may explain delayed- versus rapid-onset antidepressant efficacy. Neuropsychopharmacology 40, 2165–2174. (doi:10.1038/npp.2015.59)
58. Der-Avakian A, Barnes SA, Markou A, Pizzagalli DA. 2016 Translational assessment of reward and motivational deficits in psychiatric disorders. Curr. Top. Behav. Neurosci. 28, 231–262. (doi:10.1007/7854_2015_5004)
59. Der-Avakian A, D’Souza MS, Pizzagalli DA, Markou A. 2013 Assessment of reward responsiveness in the response bias probabilistic reward task in rats: implications for cross-species translational research. Transl. Psychiatry 3, e297. (doi:10.1038/tp.2013.74)
60. Bari A, Theobald DE, Caprioli D, Mar AC, Aidoo-Micah A, Dalley JW, Robbins TW. 2010 Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats. Neuropsychopharmacology 35, 1290–1301. (doi:10.1038/npp.2009.233)
61. Harding EJ, Paul ES, Mendl M. 2004 Animal behaviour: cognitive bias and affective state. Nature 427, 312. (doi:10.1038/427312a)
62. Enkel T, Gholizadeh D, von Bohlen und Halbach O, Sanchis-Segura C, Hurlemann R, Spanagel R, Gass P, Vollmayr B. 2010 Ambiguous-cue interpretation is biased under stress- and depression-like states in rats. Neuropsychopharmacology 35, 1008–1015. (doi:10.1038/npp.2009.204)
63. Papciak J, Popik P, Fuchs E, Rygula R. 2013 Chronic psychosocial stress makes rats more ‘pessimistic’ in the ambiguous-cue interpretation paradigm. Behav. Brain Res. 256, 305–310. (doi:10.1016/j.bbr.2013. 08.036)
64. Anderson MH, Munafò MR, Robinson ES. 2013 Investigating the psychopharmacology of cognitive affective bias in rats using an affective tone discrimination task. Psychopharmacology (Berl.) 226, 601–613. (doi:10.1007/s00213-012-2932-5)
65. Hales CA, Robinson ES, Houghton CJ. 2016 Diffusion modelling reveals the decision making processes underlying negative judgement bias in rats. PLoS ONE 11, e0152592. (doi:10.1371/journal.pone. 0152592)
66. Rygula R, Papciak J, Popik P. 2013 Trait pessimism predicts vulnerability to stress-induced anhedonia in rats. Neuropsychopharmacology 38, 2188–2196. (doi:10.1038/npp.2013.116)
67. Rygula R, Papciak J, Popik P. 2014 The effects of acute pharmacological stimulation of the 5-HT, NA and DA systems on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm. Eur. Neuropsychopharmacol. 24, 1103–1111. (doi:10.1016/j.euroneuro.2014.01.012)
68. Rygula R, Szczech E, Papciak J, Nikiforuk A, Popik P. 2014 The effects of cocaine and mazindol on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm. Behav. Brain Res. 270, 206–212. (doi:10.1016/j.bbr.2014.05.026)
69. Hales CA, Houghton CJ, Robinson ESJ. 2017 Behavioural and computational methods reveal differential effects for how delayed and rapid onset antidepressants effect decision making in rats. Eur. Neuropsychopharmacol. 27, 1268–1280. (doi:10. 1016/j.euroneuro.2017.09.008)
70. Anderson MH, Hardcastle C, Munafò MR, Robinson ESJ. 2012 Evaluation of a novel translational task for assessing emotional biases in different species. Cogn. Affect. Behav. Neurosci. 12, 373–381. (doi:10. 3758/s13415-011-0076-4)
71. Rzepa E, Fisk J, McCabe C. 2017 Blunted neural response to anticipation, effort and consummation of reward and aversion in adolescents with depression symptomatology. J. Psychopharmacol. 31, 303–311. (doi:10.1177/0269881116681416)
72. McCabe C. 2016 Neural signals of ‘intensity’ but not ‘wanting’ or ‘liking’ of rewards may be trait markers for depression. J. Psychopharmacol. 30, 1020–1027. (doi:10.1177/0269881116653079)
73. McCabe C, Cowen PJ, Harmer CJ. 2009 Neural representation of reward in recovered depressed patients. Psychopharmacology (Berl.) 205, 667– 677. (doi:10.1007/s00213-009-1573-9)
74. Wood CM et al. 2017 Prevalence and influence of cys407* Grm2 mutation in Hannover-derived Wistar rats: mGlu2 receptor loss links to alcohol intake, risk taking and emotional behaviour. Neuropharmacology 115, 128–138. (doi:10.1016/j. neuropharm.2016.03.020)
75. Stuart SA, Wood CM, Robinson ESJ. 2017 Using the affective bias test to predict drug-induced negative affect: implications for drug safety. Br. J. Pharmacol. 174, 3200–3210. (doi:10.1111/bph.13972)
76. Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, Jerabek PA. 2000 Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol. Psychiatry 48, 830–843. (doi:10.1016/S0006-3223(00)01036-2)
77. Hamani C, Mayberg H, Stone S, Laxton A, Haber S, Lozano AM. 2011 The subcallosal cingulate gyrus in the context of major depression. Biol. Psychiatry 69, 301–308. (doi:10.1016/j.biopsych.2010.09.034)
78. Hinchcliffe JK, Stuart SA, Mendl M, Robinson EMJ. 2017 Further validation of the affective bias test for predicting antidepressant and pro-depressant risk: effects of pharmacological and social manipulations in male and female rats. Psychopharmacology (Berl) 234, 3105–3116. (doi:10.1007/s00213-017-4687-5)
79. Gourley SL, Taylor JR. 2009 Recapitulation and reversal of a persistent depression-like syndrome in rodents. Curr. Protoc. Neurosci. Chapter 9, Unit 9.32. (doi:10.1002/0471142301.ns0932s49)
80. Gregus A, Wintink AJ, Davis AC, Kalynchuk LE. 2005 Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav. Brain Res. 156, 105– 114. (doi:10.1016/j.bbr.2004.05.013)
81. Kosel M, Bilkei-Gorzo A, Zawatzky R, Zimmer A, Schlaepfer TE. 2011 Pegylated human interferon alpha 2a does not induce depression-associated changes in mice. Psychiatry Res. 185, 243–247. (doi:10.1016/j.psychres.2009.10.012)
82. Shalev U, Kafkafi N. 2002 Repeated maternal separation does not alter sucrose-reinforced and open-field behaviors. Pharmacol. Biochem. Behav. 73, 115–122. (doi:10.1016/S0091-3057(02)00756-6)
83. Griebel G, Stemmelin J, Scatton B. 2005 Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents. Biol. Psychiatry 57, 261–267. (doi:10. 1016/j.biopsych.2004.10.032)
84. Sahin C, Doostdar N, Neill JC. 2016 Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model. Behav. Brain Res. 312, 93–101. (doi:10. 1016/j.bbr.2016.06.021)
85. Jenkins TA, Harte MK, Reynolds GP. 2010 Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat. Neurosci. Lett. 471, 144–147. (doi:10.1016/j.neulet.2010.01.028)
86. Berton O, Nestler EJ. 2006 New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 7, 137–151. (doi:10.1038/nrn1846)
87. Duman RS, Monteggia LM. 2006 A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59, 1116–1127. (doi:10.1016/j.biopsych. 2006.02.013)
88. Phillips C. 2017 Brain-derived neurotrophic factor, depression, and physical activity: making the neuroplastic connection. Neural Plast. 2017, 7260130. (doi:10.1155/2017/7260130)
89. Duman RS, Li N. 2012 A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Phil. Trans R. Soc. B 367, 2475–2484. (doi:10.1098/rstb.2011.0357)
90. Harmer CJ, Duman RS, Cowen PJ. 2017 How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry 4, 409–418. (doi:10.1016/S2215-0366(17)30015-9)
91. Duman RS. 2014 Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections. Depress Anxiety 31, 291–296. (doi:10.1002/da.22227)
92. Duman RS, Li N. 2012 A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Phil. Trans. R. Soc. B 367, 2475–2484. (doi:10.1098/rstb.2011.0357)
93. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng P-f, Kavalali ET. 2011 NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 91–95. (doi:10.1038/nature10130)
94. Li N, Lee B, Liu R-J, Banasr M, Dwyer JM, Iwata M, Li X-Y, Aghajanian G, Duman RS. 2010 mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959–964. (doi:10.1126/science.1190287)
95. Groves JO. 2007 Is it time to reassess the BDNF hypothesis of depression? Mol. Psychiatry 12, 1079–1088. (doi:10.1038/sj.mp.4002075)
96. McKinnon MC, Yucel K, Nazarov A, MacQueen GM. 2009 A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J. Psychiatry Neurosci. 34, 41–54.
97. Burger DK, Saucier JM, Iwaniuk AN, Saucier DM. 2013 Seasonal and sex differences in the hippocampus of a wild rodent. Behav. Brain Res. 236, 131–138. (doi:10.1016/j.bbr.2012.08.044)
98. Huttenrauch M, Salinas G, Wirths O. 2016 Effects of long-term environmental enrichment on anxiety, memory, hippocampal plasticity and overall brain gene expression in C57BL6 mice. Front. Mol. Neurosci. 9, 62. (doi:10.3389/fnmol.2016.00062)
99. Woollett K, Maguire EA. 2011 Acquiring ‘the knowledge’ of London’s layout drives structural brain changes. Curr. Biol. 21, 2109–2114. (doi:10. 1016/j.cub.2011.11.018)
100. Hales CA, Houghton CJ, Robinson ESJ. 2017 Behavioural and computational methods reveal differential effects for how delayed and rapid onset antidepressants effect decision making in rats. Eur. Neuropsychopharmacol. 27, 1268–1280. (doi:10. 1016/j.euroneuro.2017.09.008)